(Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.

(Reuters) -The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree about whether pharmaceutical company Boehringer Ingelheim ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

A Chicago jury failed to reach a verdict Sept. 18 over claims that heartburn drug Zantac causes cancer, Reuters exclusively reported. The case, brought by Illinois resident Ronald Kimbrow, alleged ...

He is accusing GSK, formerly known as GlaxoSmithKline, of hiding the cancer risks of its once-popular heartburn drug, Zantac. Yost filed a motion on Monday requesting that the Ohio Public Employees ...

The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...

The U.S. Food and Drug Administration announced Wednesday it is requesting manufacturers remove all prescription and over-the-counter ranitidine drugs from the market immediately. This is the latest ...